Web Designer, Author, Portfolio Manager, Quantitative, Technical & Qualitative Analyst•
Share:
Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at Barclays from an "equal weight" rating to an "overweight" rating. They now have a $73.00 price target on the stock, up previously from $67.00. 18.5% upside from the previous close of $61.58. Tweet This.
Latest Upgrade:
Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at Barclays from an "equal weight" rating to an "overweight" rating. They now have a $73.00 price target on the stock, up previously from $67.00. 18.5% upside from the previous close of $61.58. Tweet This.
Disclaimer:This and other personal blog posts are not reviewed, monitored or endorsed by
TalkMarkets. The content is solely the view of the author and TalkMarkets is not
responsible for the content of this post in any way. Our curated content which is
handpicked by our editorial team may be viewed here.
Comments
Log in or sign up to join the conversation.